International Clinical Trial: Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (NCT07579689) titled 'Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment' on May 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Hanyang University

Condition: Mild Cognitive Impairment Alzheimer's Disease

Intervention: Drug: Ginkgo Biloba Extract 240 mg

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: June 2026

Target Sample Size: 120

To know more, visit https://clinicaltrials.gov/study/NCT0...